Global OTC Gastrointestinal Products Market Growth 2025-2031

December 2025 | 94 pages | ID: G24FF879ADEEN
LP Information

Abstracts

The global OTC Gastrointestinal Products market size is predicted to grow from US$ 6656 million in 2025 to US$ 9230 million in 2031; it is expected to grow at a CAGR of 5.6% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

OTC gastrointestinal agents include many different classes of drugs that are used to treat gastrointestinal disorders.

United States market for OTC Gastrointestinal Products is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for OTC Gastrointestinal Products is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for OTC Gastrointestinal Products is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key OTC Gastrointestinal Products players cover GlaxoSmithKline, Merck, Novartis, Bayer, Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “OTC Gastrointestinal Products Industry Forecast” looks at past sales and reviews total world OTC Gastrointestinal Products sales in 2024, providing a comprehensive analysis by region and market sector of projected OTC Gastrointestinal Products sales for 2025 through 2031. With OTC Gastrointestinal Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world OTC Gastrointestinal Products industry.

This Insight Report provides a comprehensive analysis of the global OTC Gastrointestinal Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on OTC Gastrointestinal Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global OTC Gastrointestinal Products market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for OTC Gastrointestinal Products and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global OTC Gastrointestinal Products.

This report presents a comprehensive overview, market shares, and growth opportunities of OTC Gastrointestinal Products market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• H2 Receptor Antagonists
• Proton Pump Inhibitors (PPIs)

Segmentation by Application:

• Hospital Pharmacies
• Drug Stores
• Retail Stores
• E-Commerce

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• GlaxoSmithKline
• Merck
• Novartis
• Bayer
• Pfizer
• Bristol-Myers Squibb

Key Questions Addressed in this Report

What is the 10-year outlook for the global OTC Gastrointestinal Products market?

What factors are driving OTC Gastrointestinal Products market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do OTC Gastrointestinal Products market opportunities vary by end market size?

How does OTC Gastrointestinal Products break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global OTC Gastrointestinal Products Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for OTC Gastrointestinal Products by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for OTC Gastrointestinal Products by Country/Region, 2020, 2024 & 2031
2.2 OTC Gastrointestinal Products Segment by Type
  2.2.1 H2 Receptor Antagonists
  2.2.2 Proton Pump Inhibitors (PPIs)
2.3 OTC Gastrointestinal Products Sales by Type
  2.3.1 Global OTC Gastrointestinal Products Sales Market Share by Type (2020-2025)
  2.3.2 Global OTC Gastrointestinal Products Revenue and Market Share by Type (2020-2025)
  2.3.3 Global OTC Gastrointestinal Products Sale Price by Type (2020-2025)
2.4 OTC Gastrointestinal Products Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Drug Stores
  2.4.3 Retail Stores
  2.4.4 E-Commerce
2.5 OTC Gastrointestinal Products Sales by Application
  2.5.1 Global OTC Gastrointestinal Products Sale Market Share by Application (2020-2025)
  2.5.2 Global OTC Gastrointestinal Products Revenue and Market Share by Application (2020-2025)
  2.5.3 Global OTC Gastrointestinal Products Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global OTC Gastrointestinal Products Breakdown Data by Company
  3.1.1 Global OTC Gastrointestinal Products Annual Sales by Company (2020-2025)
  3.1.2 Global OTC Gastrointestinal Products Sales Market Share by Company (2020-2025)
3.2 Global OTC Gastrointestinal Products Annual Revenue by Company (2020-2025)
  3.2.1 Global OTC Gastrointestinal Products Revenue by Company (2020-2025)
  3.2.2 Global OTC Gastrointestinal Products Revenue Market Share by Company (2020-2025)
3.3 Global OTC Gastrointestinal Products Sale Price by Company
3.4 Key Manufacturers OTC Gastrointestinal Products Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers OTC Gastrointestinal Products Product Location Distribution
  3.4.2 Players OTC Gastrointestinal Products Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR OTC GASTROINTESTINAL PRODUCTS BY GEOGRAPHIC REGION

4.1 World Historic OTC Gastrointestinal Products Market Size by Geographic Region (2020-2025)
  4.1.1 Global OTC Gastrointestinal Products Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global OTC Gastrointestinal Products Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic OTC Gastrointestinal Products Market Size by Country/Region (2020-2025)
  4.2.1 Global OTC Gastrointestinal Products Annual Sales by Country/Region (2020-2025)
  4.2.2 Global OTC Gastrointestinal Products Annual Revenue by Country/Region (2020-2025)
4.3 Americas OTC Gastrointestinal Products Sales Growth
4.4 APAC OTC Gastrointestinal Products Sales Growth
4.5 Europe OTC Gastrointestinal Products Sales Growth
4.6 Middle East & Africa OTC Gastrointestinal Products Sales Growth

5 AMERICAS

5.1 Americas OTC Gastrointestinal Products Sales by Country
  5.1.1 Americas OTC Gastrointestinal Products Sales by Country (2020-2025)
  5.1.2 Americas OTC Gastrointestinal Products Revenue by Country (2020-2025)
5.2 Americas OTC Gastrointestinal Products Sales by Type (2020-2025)
5.3 Americas OTC Gastrointestinal Products Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC OTC Gastrointestinal Products Sales by Region
  6.1.1 APAC OTC Gastrointestinal Products Sales by Region (2020-2025)
  6.1.2 APAC OTC Gastrointestinal Products Revenue by Region (2020-2025)
6.2 APAC OTC Gastrointestinal Products Sales by Type (2020-2025)
6.3 APAC OTC Gastrointestinal Products Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe OTC Gastrointestinal Products by Country
  7.1.1 Europe OTC Gastrointestinal Products Sales by Country (2020-2025)
  7.1.2 Europe OTC Gastrointestinal Products Revenue by Country (2020-2025)
7.2 Europe OTC Gastrointestinal Products Sales by Type (2020-2025)
7.3 Europe OTC Gastrointestinal Products Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa OTC Gastrointestinal Products by Country
  8.1.1 Middle East & Africa OTC Gastrointestinal Products Sales by Country (2020-2025)
  8.1.2 Middle East & Africa OTC Gastrointestinal Products Revenue by Country (2020-2025)
8.2 Middle East & Africa OTC Gastrointestinal Products Sales by Type (2020-2025)
8.3 Middle East & Africa OTC Gastrointestinal Products Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of OTC Gastrointestinal Products
10.3 Manufacturing Process Analysis of OTC Gastrointestinal Products
10.4 Industry Chain Structure of OTC Gastrointestinal Products

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 OTC Gastrointestinal Products Distributors
11.3 OTC Gastrointestinal Products Customer

12 WORLD FORECAST REVIEW FOR OTC GASTROINTESTINAL PRODUCTS BY GEOGRAPHIC REGION

12.1 Global OTC Gastrointestinal Products Market Size Forecast by Region
  12.1.1 Global OTC Gastrointestinal Products Forecast by Region (2026-2031)
  12.1.2 Global OTC Gastrointestinal Products Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global OTC Gastrointestinal Products Forecast by Type (2026-2031)
12.7 Global OTC Gastrointestinal Products Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 GlaxoSmithKline
  13.1.1 GlaxoSmithKline Company Information
  13.1.2 GlaxoSmithKline OTC Gastrointestinal Products Product Portfolios and Specifications
  13.1.3 GlaxoSmithKline OTC Gastrointestinal Products Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 GlaxoSmithKline Main Business Overview
  13.1.5 GlaxoSmithKline Latest Developments
13.2 Merck
  13.2.1 Merck Company Information
  13.2.2 Merck OTC Gastrointestinal Products Product Portfolios and Specifications
  13.2.3 Merck OTC Gastrointestinal Products Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Merck Main Business Overview
  13.2.5 Merck Latest Developments
13.3 Novartis
  13.3.1 Novartis Company Information
  13.3.2 Novartis OTC Gastrointestinal Products Product Portfolios and Specifications
  13.3.3 Novartis OTC Gastrointestinal Products Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Novartis Main Business Overview
  13.3.5 Novartis Latest Developments
13.4 Bayer
  13.4.1 Bayer Company Information
  13.4.2 Bayer OTC Gastrointestinal Products Product Portfolios and Specifications
  13.4.3 Bayer OTC Gastrointestinal Products Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Bayer Main Business Overview
  13.4.5 Bayer Latest Developments
13.5 Pfizer
  13.5.1 Pfizer Company Information
  13.5.2 Pfizer OTC Gastrointestinal Products Product Portfolios and Specifications
  13.5.3 Pfizer OTC Gastrointestinal Products Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Pfizer Main Business Overview
  13.5.5 Pfizer Latest Developments
13.6 Bristol-Myers Squibb
  13.6.1 Bristol-Myers Squibb Company Information
  13.6.2 Bristol-Myers Squibb OTC Gastrointestinal Products Product Portfolios and Specifications
  13.6.3 Bristol-Myers Squibb OTC Gastrointestinal Products Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Bristol-Myers Squibb Main Business Overview
  13.6.5 Bristol-Myers Squibb Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. OTC Gastrointestinal Products Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. OTC Gastrointestinal Products Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of H2 Receptor Antagonists
Table 4. Major Players of Proton Pump Inhibitors (PPIs)
Table 5. Global OTC Gastrointestinal Products Sales by Type (2020-2025) & (K Units)
Table 6. Global OTC Gastrointestinal Products Sales Market Share by Type (2020-2025)
Table 7. Global OTC Gastrointestinal Products Revenue by Type (2020-2025) & ($ million)
Table 8. Global OTC Gastrointestinal Products Revenue Market Share by Type (2020-2025)
Table 9. Global OTC Gastrointestinal Products Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global OTC Gastrointestinal Products Sale by Application (2020-2025) & (K Units)
Table 11. Global OTC Gastrointestinal Products Sale Market Share by Application (2020-2025)
Table 12. Global OTC Gastrointestinal Products Revenue by Application (2020-2025) & ($ million)
Table 13. Global OTC Gastrointestinal Products Revenue Market Share by Application (2020-2025)
Table 14. Global OTC Gastrointestinal Products Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global OTC Gastrointestinal Products Sales by Company (2020-2025) & (K Units)
Table 16. Global OTC Gastrointestinal Products Sales Market Share by Company (2020-2025)
Table 17. Global OTC Gastrointestinal Products Revenue by Company (2020-2025) & ($ millions)
Table 18. Global OTC Gastrointestinal Products Revenue Market Share by Company (2020-2025)
Table 19. Global OTC Gastrointestinal Products Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers OTC Gastrointestinal Products Producing Area Distribution and Sales Area
Table 21. Players OTC Gastrointestinal Products Products Offered
Table 22. OTC Gastrointestinal Products Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global OTC Gastrointestinal Products Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global OTC Gastrointestinal Products Sales Market Share Geographic Region (2020-2025)
Table 27. Global OTC Gastrointestinal Products Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global OTC Gastrointestinal Products Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global OTC Gastrointestinal Products Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global OTC Gastrointestinal Products Sales Market Share by Country/Region (2020-2025)
Table 31. Global OTC Gastrointestinal Products Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global OTC Gastrointestinal Products Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas OTC Gastrointestinal Products Sales by Country (2020-2025) & (K Units)
Table 34. Americas OTC Gastrointestinal Products Sales Market Share by Country (2020-2025)
Table 35. Americas OTC Gastrointestinal Products Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas OTC Gastrointestinal Products Sales by Type (2020-2025) & (K Units)
Table 37. Americas OTC Gastrointestinal Products Sales by Application (2020-2025) & (K Units)
Table 38. APAC OTC Gastrointestinal Products Sales by Region (2020-2025) & (K Units)
Table 39. APAC OTC Gastrointestinal Products Sales Market Share by Region (2020-2025)
Table 40. APAC OTC Gastrointestinal Products Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC OTC Gastrointestinal Products Sales by Type (2020-2025) & (K Units)
Table 42. APAC OTC Gastrointestinal Products Sales by Application (2020-2025) & (K Units)
Table 43. Europe OTC Gastrointestinal Products Sales by Country (2020-2025) & (K Units)
Table 44. Europe OTC Gastrointestinal Products Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe OTC Gastrointestinal Products Sales by Type (2020-2025) & (K Units)
Table 46. Europe OTC Gastrointestinal Products Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa OTC Gastrointestinal Products Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa OTC Gastrointestinal Products Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa OTC Gastrointestinal Products Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa OTC Gastrointestinal Products Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of OTC Gastrointestinal Products
Table 52. Key Market Challenges & Risks of OTC Gastrointestinal Products
Table 53. Key Industry Trends of OTC Gastrointestinal Products
Table 54. OTC Gastrointestinal Products Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. OTC Gastrointestinal Products Distributors List
Table 57. OTC Gastrointestinal Products Customer List
Table 58. Global OTC Gastrointestinal Products Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global OTC Gastrointestinal Products Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas OTC Gastrointestinal Products Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas OTC Gastrointestinal Products Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC OTC Gastrointestinal Products Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC OTC Gastrointestinal Products Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe OTC Gastrointestinal Products Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe OTC Gastrointestinal Products Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa OTC Gastrointestinal Products Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa OTC Gastrointestinal Products Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global OTC Gastrointestinal Products Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global OTC Gastrointestinal Products Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global OTC Gastrointestinal Products Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global OTC Gastrointestinal Products Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. GlaxoSmithKline Basic Information, OTC Gastrointestinal Products Manufacturing Base, Sales Area and Its Competitors
Table 73. GlaxoSmithKline OTC Gastrointestinal Products Product Portfolios and Specifications
Table 74. GlaxoSmithKline OTC Gastrointestinal Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. GlaxoSmithKline Main Business
Table 76. GlaxoSmithKline Latest Developments
Table 77. Merck Basic Information, OTC Gastrointestinal Products Manufacturing Base, Sales Area and Its Competitors
Table 78. Merck OTC Gastrointestinal Products Product Portfolios and Specifications
Table 79. Merck OTC Gastrointestinal Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Merck Main Business
Table 81. Merck Latest Developments
Table 82. Novartis Basic Information, OTC Gastrointestinal Products Manufacturing Base, Sales Area and Its Competitors
Table 83. Novartis OTC Gastrointestinal Products Product Portfolios and Specifications
Table 84. Novartis OTC Gastrointestinal Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Novartis Main Business
Table 86. Novartis Latest Developments
Table 87. Bayer Basic Information, OTC Gastrointestinal Products Manufacturing Base, Sales Area and Its Competitors
Table 88. Bayer OTC Gastrointestinal Products Product Portfolios and Specifications
Table 89. Bayer OTC Gastrointestinal Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Bayer Main Business
Table 91. Bayer Latest Developments
Table 92. Pfizer Basic Information, OTC Gastrointestinal Products Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer OTC Gastrointestinal Products Product Portfolios and Specifications
Table 94. Pfizer OTC Gastrointestinal Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Pfizer Main Business
Table 96. Pfizer Latest Developments
Table 97. Bristol-Myers Squibb Basic Information, OTC Gastrointestinal Products Manufacturing Base, Sales Area and Its Competitors
Table 98. Bristol-Myers Squibb OTC Gastrointestinal Products Product Portfolios and Specifications
Table 99. Bristol-Myers Squibb OTC Gastrointestinal Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Bristol-Myers Squibb Main Business
Table 101. Bristol-Myers Squibb Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of OTC Gastrointestinal Products
Figure 2. OTC Gastrointestinal Products Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global OTC Gastrointestinal Products Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global OTC Gastrointestinal Products Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. OTC Gastrointestinal Products Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. OTC Gastrointestinal Products Sales Market Share by Country/Region (2024)
Figure 10. OTC Gastrointestinal Products Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of H2 Receptor Antagonists
Figure 12. Product Picture of Proton Pump Inhibitors (PPIs)
Figure 13. Global OTC Gastrointestinal Products Sales Market Share by Type in 2025
Figure 14. Global OTC Gastrointestinal Products Revenue Market Share by Type (2020-2025)
Figure 15. OTC Gastrointestinal Products Consumed in Hospital Pharmacies
Figure 16. Global OTC Gastrointestinal Products Market: Hospital Pharmacies (2020-2025) & (K Units)
Figure 17. OTC Gastrointestinal Products Consumed in Drug Stores
Figure 18. Global OTC Gastrointestinal Products Market: Drug Stores (2020-2025) & (K Units)
Figure 19. OTC Gastrointestinal Products Consumed in Retail Stores
Figure 20. Global OTC Gastrointestinal Products Market: Retail Stores (2020-2025) & (K Units)
Figure 21. OTC Gastrointestinal Products Consumed in E-Commerce
Figure 22. Global OTC Gastrointestinal Products Market: E-Commerce (2020-2025) & (K Units)
Figure 23. Global OTC Gastrointestinal Products Sale Market Share by Application (2024)
Figure 24. Global OTC Gastrointestinal Products Revenue Market Share by Application in 2025
Figure 25. OTC Gastrointestinal Products Sales by Company in 2025 (K Units)
Figure 26. Global OTC Gastrointestinal Products Sales Market Share by Company in 2025
Figure 27. OTC Gastrointestinal Products Revenue by Company in 2025 ($ millions)
Figure 28. Global OTC Gastrointestinal Products Revenue Market Share by Company in 2025
Figure 29. Global OTC Gastrointestinal Products Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global OTC Gastrointestinal Products Revenue Market Share by Geographic Region in 2025
Figure 31. Americas OTC Gastrointestinal Products Sales 2020-2025 (K Units)
Figure 32. Americas OTC Gastrointestinal Products Revenue 2020-2025 ($ millions)
Figure 33. APAC OTC Gastrointestinal Products Sales 2020-2025 (K Units)
Figure 34. APAC OTC Gastrointestinal Products Revenue 2020-2025 ($ millions)
Figure 35. Europe OTC Gastrointestinal Products Sales 2020-2025 (K Units)
Figure 36. Europe OTC Gastrointestinal Products Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa OTC Gastrointestinal Products Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa OTC Gastrointestinal Products Revenue 2020-2025 ($ millions)
Figure 39. Americas OTC Gastrointestinal Products Sales Market Share by Country in 2025
Figure 40. Americas OTC Gastrointestinal Products Revenue Market Share by Country (2020-2025)
Figure 41. Americas OTC Gastrointestinal Products Sales Market Share by Type (2020-2025)
Figure 42. Americas OTC Gastrointestinal Products Sales Market Share by Application (2020-2025)
Figure 43. United States OTC Gastrointestinal Products Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada OTC Gastrointestinal Products Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico OTC Gastrointestinal Products Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil OTC Gastrointestinal Products Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC OTC Gastrointestinal Products Sales Market Share by Region in 2025
Figure 48. APAC OTC Gastrointestinal Products Revenue Market Share by Region (2020-2025)
Figure 49. APAC OTC Gastrointestinal Products Sales Market Share by Type (2020-2025)
Figure 50. APAC OTC Gastrointestinal Products Sales Market Share by Application (2020-2025)
Figure 51. China OTC Gastrointestinal Products Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan OTC Gastrointestinal Products Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea OTC Gastrointestinal Products Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia OTC Gastrointestinal Products Revenue Growth 2020-2025 ($ millions)
Figure 55. India OTC Gastrointestinal Products Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia OTC Gastrointestinal Products Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan OTC Gastrointestinal Products Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe OTC Gastrointestinal Products Sales Market Share by Country in 2025
Figure 59. Europe OTC Gastrointestinal Products Revenue Market Share by Country (2020-2025)
Figure 60. Europe OTC Gastrointestinal Products Sales Market Share by Type (2020-2025)
Figure 61. Europe OTC Gastrointestinal Products Sales Market Share by Application (2020-2025)
Figure 62. Germany OTC Gastrointestinal Products Revenue Growth 2020-2025 ($ millions)
Figure 63. France OTC Gastrointestinal Products Revenue Growth 2020-2025 ($ millions)
Figure 64. UK OTC Gastrointestinal Products Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy OTC Gastrointestinal Products Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia OTC Gastrointestinal Products Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa OTC Gastrointestinal Products Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa OTC Gastrointestinal Products Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa OTC Gastrointestinal Products Sales Market Share by Application (2020-2025)
Figure 70. Egypt OTC Gastrointestinal Products Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa OTC Gastrointestinal Products Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel OTC Gastrointestinal Products Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey OTC Gastrointestinal Products Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries OTC Gastrointestinal Products Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of OTC Gastrointestinal Products in 2025
Figure 76. Manufacturing Process Analysis of OTC Gastrointestinal Products
Figure 77. Industry Chain Structure of OTC Gastrointestinal Products
Figure 78. Channels of Distribution
Figure 79. Global OTC Gastrointestinal Products Sales Market Forecast by Region (2026-2031)
Figure 80. Global OTC Gastrointestinal Products Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global OTC Gastrointestinal Products Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global OTC Gastrointestinal Products Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global OTC Gastrointestinal Products Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global OTC Gastrointestinal Products Revenue Market Share Forecast by Application (2026-2031)